MPI of Biochemistry and GSK collaborate in development of new drugs for type 2 diabetes
Links shared publicly online about this topic.
- 790total visits
MPI of Biochemistry and GSK collaborate in development of new drugs for type 2 diabetes
The recently signed cooperation agreement between the MPI of Biochemistry and GSK pursues the objective of developing innovative new drugs. The joint research and development work is based on the research findings of Axel Ullrich, Director at the MPI of Biochemistry.
View full resource at news-medical.net
Tags: Diabetes, Type 2 Diabetes, Joint, Drug, GlaxoSmithKline, Science
Most Recently Shared on October 19, 2010 at 9:48 am By:
MPI of Biochemistry and GSK collaborate in development of new drugs for type 2 diabetes: The recently signed coope... http://bit.ly/boUFtG
Advertisement
